We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The company expects the diagnostic tests to be in high demand in Europe, where most of the molecular testing is performed in decentralized hospital settings. Read More
The firm has a distribution agreement with Micro-Tech Endoscopy USA, which will begin phased distribution of the system to U.S. hospitals and surgery centers. Read More
Clinical use of the bioactive glass is supported by a 30-year history of research and more than 200 peer-reviewed publications, the company said. Read More
The company plans to roll out the mobile bolus feature throughout the spring in a series of limited launches, followed by an expanded launch later this summer. Read More
NPseal delivers the same type of negative pressure wound therapy as the currently available, more expensive and complex devices, the company said. Read More
In a 30-patient multicenter retrospective analysis of the device’s use, 97 percent of patients showed an increase in vessel opening of at least 25 percent, with 80 percent of patients showing an increase of 50 percent or more. Read More